View Item 

Show simple item record

Mapping Geographic Areas of High and Low Drug Adherence in Patients Prescribed Continuing Treatment for Acute Coronary Syndrome After Discharge

dc.contributor.authorHoang, Cuongen_US
dc.contributor.authorKolenic, Giselleen_US
dc.contributor.authorKline‐rogers, Eva M.en_US
dc.contributor.authorEagle, Kim A.en_US
dc.contributor.authorErickson, Steven R.en_US
dc.date.accessioned2012-03-16T15:58:31Z
dc.date.available2012-12-03T21:17:29Zen_US
dc.date.issued2011-10en_US
dc.identifier.citationHoang, Cuong; Kolenic, Giselle; Kline‐rogers, Eva ; Eagle, Kim A.; Erickson, Steven R. (2011). "Mapping Geographic Areas of High and Low Drug Adherence in Patients Prescribed Continuing Treatment for Acute Coronary Syndrome After Discharge." Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 31(10). <http://hdl.handle.net/2027.42/90283>en_US
dc.identifier.issn0277-0008en_US
dc.identifier.issn1875-9114en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/90283
dc.publisherWiley Periodicals, Inc.en_US
dc.publisherBlackwell Publishing Ltden_US
dc.subject.otherGISen_US
dc.subject.otherMedication Adherenceen_US
dc.subject.otherCardiovascular Diseaseen_US
dc.subject.otherAcute Coronary Syndromeen_US
dc.subject.otherACSen_US
dc.subject.otherGeographic Information Systemen_US
dc.subject.otherMedication Persistenceen_US
dc.titleMapping Geographic Areas of High and Low Drug Adherence in Patients Prescribed Continuing Treatment for Acute Coronary Syndrome After Dischargeen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumCardiovascular Center, University of Michigan Health System, Ann Arbor, Michigan.en_US
dc.contributor.affiliationumCenter for Statistical Consultation and Research, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationotherCollege of Pharmacy, Ann Arbor, Michigan.en_US
dc.contributor.affiliationotherDepartment of Internal Medicine, Ann Arbor, Michigan.en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/90283/1/phco.31.10.927.pdf
dc.identifier.doi10.1592/phco.31.10.927en_US
dc.identifier.sourcePharmacotherapy: The Journal of Human Pharmacology and Drug Therapyen_US
dc.identifier.citedreferenceRoux Diez AV, Evenson KR, McGinn AP, et al. Availability of recreational resources and physical activity in adults. Am J Public Health 2007; 97: 493 – 9.en_US
dc.identifier.citedreferenceGallagher E., Viscoli C., Horwitz R. The relationship of treatment adherence to the risk of death after myocardial infarction in women. JAMA 1993; 270: 742 – 4.en_US
dc.identifier.citedreferenceHo M., Peterson E., Wang L., et al. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA 2008; 299: 532 – 9.en_US
dc.identifier.citedreferenceSud A., Kline‐Rogers E., Eagle K., et al. Adherence to medications by patients after acute coronary syndromes. Ann Pharmacother 2005; 39: 1792 – 7.en_US
dc.identifier.citedreferenceKennedy J., Coyne J., Sclar D. Drug affordability and prescription noncompliance in the United States: 1997–2002. Clin Ther 2004; 26: 607 – 14.en_US
dc.identifier.citedreferenceRice T., Lavarreda SA, Ponce NA, Brown RB. The impact of private and public health insurance on medication use for adults with chronic diseases. Med Care Res Rev 2005; 62: 231 – 49.en_US
dc.identifier.citedreferenceBalkrishnan R. Predictors of medication adherence in the elderly. Clin Ther 1998; 20: 764 – 71.en_US
dc.identifier.citedreferenceDunbar‐Jacob J., Mortimer‐Stephens M. Treatment adherence in chronic disease. J Clin Epid 2001; 54: S57 – 60.en_US
dc.identifier.citedreferenceBurke L., Dunbar‐Jacob J., Hill M. Compliance with cardiovascular disease prevention strategies: a review of the research. Ann Behav Med 1997; 19: 239 – 63.en_US
dc.identifier.citedreferenceJackevicius C., Li P., Tu J. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation 2008; 117: 1028 – 36.en_US
dc.identifier.citedreferenceVermeire E., Hearnshaw H., Van Royen P. Patient adherence to treatment: three decades of research—a comprehensive review. J Clin Pharm Ther 2001; 26: 331 – 42.en_US
dc.identifier.citedreferenceMorris LS, Schulz R. Medication compliance: the patient's perspective. Clin Ther 1993; 15: 593 – 606.en_US
dc.identifier.citedreferenceRoux Diez AV. Residential environments and cardiovascular risk. J Urban Health 2003; 80: 569 – 89.en_US
dc.identifier.citedreferenceRoux Diez AV. Persistent social patterning of cardiovascular risk. Circulation 2005; 111: 3020 – 1.en_US
dc.identifier.citedreferenceTonne C., Schwartz J., Mittleman M. Long‐term survival after acute myocardial infarction is lower in more deprived neighborhoods. Circulation 2005; 111: 3063 – 70.en_US
dc.identifier.citedreferenceIsaacs SL, Schroeder SA. Class—the ignored determinant of the nation's health. N Engl J Med 2004; 351: 1137 – 42.en_US
dc.identifier.citedreferenceMorland K., Roux Diez AV, Wing S. Supermarkets, other food stores, and obesity: the arthrosclerosis risk in communities study. Am J Prev Med 2006; 30: 333 – 9.en_US
dc.identifier.citedreferenceEgede LE, Gebregziabher M., Hunt KJ, et al. Regional, geographic, and ethnic differences in medication adherence among adults with type 2 diabetes. Ann Pharmacother 2011; 45: 169 – 78.en_US
dc.identifier.citedreferenceKing WK, Minor P., Kitchen CR, et al. Racial, gender and geographic disparities of antiretroviral treatment among U.S. Medicaid enrollees in 1998. J Epidemiol Community Health 2008; 62: 798 – 803.en_US
dc.identifier.citedreferenceZerzan JT, Morden NE, Soumerai S., et al. Trends and geographic variation of opiate medication use in state Medicaid fee‐for‐service programs, 1996–2002. Med Care 2006; 44: 1005 – 10.en_US
dc.identifier.citedreferenceMeliker JR, Sloan CD. Spatio‐temporal epidemiology: principles and opportunities [online exclusive article]. Spat Spattemporal Epidemiol 2011; 2: 1 – 9. Available from http:dx.doi.org10.1016j.sste. 2010.10.001.en_US
dc.identifier.citedreferencePeled R., Reuveni H., Pliskin JS, Beneson I., Hatna E., Tal A. Defining localities of inadequate treatment for childhood asthma: a GIS approach [online exclusive article]. Int J Health Geogr 2006; 5: 3. Available from http:www.ij‐healthgeographics.comcontent513.en_US
dc.identifier.citedreferenceCzarnecki KD, Goranson C., Ellis JA, Vichinsky LE, Coady MH, Perl SB. Using geographic information system analyses to monitor large‐scale distribution of nicotine replacement therapy in New York City. Prev Med 2010; 50: 288 – 96.en_US
dc.identifier.citedreferenceBrownstein JS, Green TC, Cassidy TA, Butler SF. Geographic information systems and pharmacoepidemiology: using spatial cluster detection to monitor local patterns of prescription opioid abuse. Pharmacoepidemiol Drug Saf 2010; 19: 627 – 37.en_US
dc.identifier.citedreferenceEagle KA, Kline‐Rogers E., Goodman SG, et al. Adherence to evidence‐based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. Am J Med 2004; 117: 73 – 81.en_US
dc.identifier.citedreferencePearson TA, Blair SN, Daniels SR, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation 2002; 106: 388 – 91.en_US
dc.identifier.citedreferenceO'Campo P. Invited commentary: advancing theory and methods for multilevel models of residential neighborhoods and health. Am J Epidemiol 2003; 157: 9 – 13.en_US
dc.identifier.citedreferenceDiez‐Roux AV. Investigating neighborhood and area effects on health. Am J Pub Health 2001; 91: 1783 – 9.en_US
dc.identifier.citedreferenceBecker M., Maiman L. Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care 1975; 3: 10 – 24.en_US
dc.identifier.citedreferenceAntman E., Anbe D., Kushner F., et al. ACC/AHA guidelines for the management of patients with ST‐elevation myocardial infarction. Circulation 2004; 110: e82 – 293.en_US
dc.identifier.citedreferenceFox K., Steg P., Eagle K., et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999–2006. JAMA 2007; 297: 1892 – 900.en_US
dc.identifier.citedreferenceJackevicius C., Mamdani M., Tu J. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002; 288: 462 – 7.en_US
dc.identifier.citedreferenceCline CMJ, Bjork‐Linne AK, Israelsson BYA, Willenheimer RB, Erhardt LR. Non‐compliance and knowledge of prescribed medication in elderly patients with heart failure. Eur J Heart Fail 1999; 1: 145 – 9.en_US
dc.identifier.citedreferenceDunbar‐Jacob J., Bohachick P., Mortimer M., Sereika SM, Foley SM. Medication adherence in persons with cardiovascular disease. J Cardiovasc Nurs 2003; 18: 209 – 18.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
phco.31.10.927.pdf
Size:
336.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.